There are 3164 resources available
Invited Discussant 1535O, 1536O and 1537O
Presenter: Dario Trapani
Session: Proffered paper session: Policy and preventive strategies
Resources:
Slides
Webcast
Invited Discussant 231O
Presenter: Charlotte Coles
Session: Presidential Symposium II: Practice-changing trials
Resources:
Slides
Webcast
LBA5 - A randomized phase III trial of neoadjuvant durvalumab plus chemotherapy followed by radical cystectomy and adjuvant durvalumab in muscle-invasive bladder cancer (NIAGARA)
Presenter: Thomas Powles
Session: Presidential Symposium II: Practice-changing trials
Resources:
Abstract
Slides
Webcast
Pharmacology and dose-selection of ADCs
Presenter: Emiliano Calvo
Session: Current advances in clinical pharmacology within oncology, and its relevance for daily practice
Resources:
Slides
Webcast
Q&A and discussion
Session: What we know and what we should know on immunotherapy and endometrial cancer (EC)
Resources:
Webcast
Impact on surgery: Other tumour locations
Presenter: Winan Van Houdt
Session: Definition and clinical implication of response in localised sarcomas
Resources:
Webcast
Q&A
Session: Proffered paper session: Policy and preventive strategies
Resources:
Webcast
1538O - Environmental pollutants and molecular alterations in non-small cell lung cancer: Insights from the KBP-2020 cohort study
Presenter: Alexis Cortot
Session: Proffered paper session: Policy and preventive strategies
Resources:
Abstract
Slides
Webcast
Conclusions
Presenter: Ron Mathijssen
Session: Current advances in clinical pharmacology within oncology, and its relevance for daily practice
Resources:
Slides
Webcast
Discussion
Session: Definition and clinical implication of response in localised sarcomas
Resources:
Webcast